In the Newsletter of January 2026 M. Amir and K. Devreese described a patient with severe Haemophilia A switching from emicizumab to efanesoctocog alfa.
In the Newsletter of January 2026 M. Amir and K. Devreese described a patient with severe Haemophilia A switching from emicizumab to efanesoctocog alfa.